TA
PCRX icon

Teachers Advisors’s Pacira BioSciences PCRX Stock Holding History

Teachers Advisors’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$10.8M Buy
283,477
+157,840
+126% +$6.16M 0.01% 964
2018
Q4 		$5.41M Buy
125,637
+31,738
+34% +$1.48M 0.01% 1265
2018
Q3 		$4.62M Buy
93,899
+17,131
+22% +$741K 0.01% 1495
2018
Q2 		$2.46M Buy
76,768
+4,848
+7% +$167K ﹤0.01% 1831
2018
Q1 		$2.24M Hold
71,920
– – ﹤0.01% 1759
2017
Q4 		$3.28M Sell
71,920
-153,463
-68% -$6.08M ﹤0.01% 1567
2017
Q3 		$8.46M Buy
225,383
+242
+0.1% +$9.74K 0.01% 1097
2017
Q2 		$10.7M Buy
225,141
+12,349
+6% +$573K 0.02% 960
2017
Q1 		$9.7M Buy
212,792
+149,938
+239% +$6.48M 0.01% 1005
2016
Q4 		$2.03M Buy
62,854
+3,658
+6% +$122K ﹤0.01% 1768
2016
Q3 		$2.03M Buy
59,196
+753
+1% +$29.5K ﹤0.01% 1685
2016
Q2 		$1.97M Buy
58,443
+4,106
+8% +$202K ﹤0.01% 1665
2016
Q1 		$2.88M Sell
54,337
-109,703
-67% -$6.42M 0.01% 1384
2015
Q4 		$12.6M Buy
164,040
+110,509
+206% +$6.26M 0.02% 759
2015
Q3 		$2.2M Buy
53,531
+466
+0.9% +$28.5K ﹤0.01% 1524
2015
Q2 		$3.75M Buy
53,065
+2,023
+4% +$159K 0.01% 1291
2015
Q1 		$4.54M Buy
51,042
+1,294
+3% +$131K 0.01% 1204
2014
Q4 		$4.41M Hold
49,748
– – 0.01% 1192
2014
Q3 		$4.82M Sell
49,748
-474
-0.9% -$46.1K 0.01% 1147
2014
Q2 		$4.61M Buy
50,222
+9,674
+24% +$737K 0.01% 1163
2014
Q1 		$2.84M Buy
40,548
+772
+2% +$52.5K 0.01% 1372
2013
Q4 		$2.29M Buy
39,776
+1,690
+4% +$88.9K 0.01% 1466
2013
Q3 		$1.83M Buy
38,086
+1,653
+5% +$60.2K ﹤0.01% 1550
2013
Q2 		$1.06M Buy
+36,433
New +$1.05M ﹤0.01% 1824

Other funds holding PCRX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Teachers Advisors's PCRX Position: Q1 2019 in Review

Teachers Advisors increased its Pacira BioSciences (PCRX) stake by 126% in Q1 2019, buying an estimated $6.16M and bringing the position to 283,477 shares worth $10.8M. The position accounts for 0.01% of the portfolio, ranked #964.

Teachers Advisors first reported a position in PCRX in Q2 2013 and has held it in 24 quarters since. The position peaked at $12.6M in Q4 2015. 210 funds tracked by Wall St. Rank hold PCRX as of Q1 2019.

  • Teachers Advisors held 283,477 shares of Pacira BioSciences worth $10.8M as of Q1 2019.
  • Teachers Advisors bought 157,840 Pacira BioSciences shares in Q1 2019, an estimated $6.16M.
  • Pacira BioSciences made up 0.01% of Teachers Advisors's portfolio in Q1 2019, its #964 holding.
  • Teachers Advisors first reported a position in Pacira BioSciences in Q2 2013 and has held it in 24 quarters since.
  • Teachers Advisors's Pacira BioSciences position peaked at $12.6M in Q4 2015.
  • 210 funds tracked by Wall St. Rank held Pacira BioSciences as of Q1 2019.

Based on Teachers Advisors's 13F filing for Q1 2019, filed 14 May 2019.